
Company valuation, historical trends, and peer comparisons.
According to Verastem, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 816.03M. This represents a change of 72.24% compared to the average of 473.77M of the last 4 quarters.
The mean historical Enterprise Value of Verastem, Inc. over the last ten years is 178.57M. The current 816.03M Enterprise Value has changed 356.97% with respect to the historical average. Over the past ten years (40 quarters), VSTM's Enterprise Value was at its highest in in the June 2021 quarter at 698.56M. The Enterprise Value was at its lowest in in the June 2023 quarter at -8664920.00.
Average
178.57M
Median
153.56M
Minimum
9.08M
Maximum
406.94M
Discovering the peaks and valleys of Verastem, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 457.50%
Maximum Annual Enterprise Value = 406.94M
Minimum Annual Increase = -91.28%
Minimum Annual Enterprise Value = 9.08M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 406.94M | 194.73% |
| 2024 | 138.07M | -3.56% |
| 2023 | 143.17M | 383.77% |
| 2022 | 29.59M | -91.28% |
| 2021 | 339.46M | 20.65% |
| 2020 | 281.35M | 71.61% |
| 2019 | 163.95M | -26.64% |
| 2018 | 223.50M | 341.64% |
| 2017 | 50.61M | 457.50% |
| 2016 | 9.08M | -78.37% |
The current Enterprise Value of Verastem, Inc. (VSTM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
229.39M
5-year avg
211.45M
10-year avg
178.57M
Verastem, Inc.’s Enterprise Value is greater than Immuneering Corporation (182.66M), greater than Prelude Therapeutics Incorporated (153.78M), less than ORIC Pharmaceuticals, Inc. (915.30M), greater than C4 Therapeutics, Inc. (381.15M), greater than Foghorn Therapeutics Inc. (94.09M), greater than Cardiff Oncology, Inc. (60.47M), less than Nuvation Bio Inc. (1.65B), greater than Acrivon Therapeutics, Inc. Common Stock (31.83M), greater than BridgeBio Oncology Therapeutics Inc. (143.27M), greater than Adlai Nortye Ltd. (394.92M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 182.66M | $237.36M | |
| 153.78M | $224.00M | |
| 915.30M | $949.46M | |
| 381.15M | $402.91M | |
| 94.09M | $119.07M | |
| 60.47M | $69.21M | |
| 1.65B | $1.65B | |
| 31.83M | $71.14M | |
| 143.27M | $194.82M | |
| 394.92M | $500.81M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verastem, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Verastem, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Verastem, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Verastem, Inc. (VSTM)?
What is the 3-year average Enterprise Value for Verastem, Inc. (VSTM)?
What is the 5-year average Enterprise Value for Verastem, Inc. (VSTM)?
How does the current Enterprise Value for Verastem, Inc. (VSTM) compare to its historical average?